ATE413390T1 - Langkettige fettalkoholsubstituenten in mitteln gegen krebs - Google Patents
Langkettige fettalkoholsubstituenten in mitteln gegen krebsInfo
- Publication number
- ATE413390T1 ATE413390T1 AT02805778T AT02805778T ATE413390T1 AT E413390 T1 ATE413390 T1 AT E413390T1 AT 02805778 T AT02805778 T AT 02805778T AT 02805778 T AT02805778 T AT 02805778T AT E413390 T1 ATE413390 T1 AT E413390T1
- Authority
- AT
- Austria
- Prior art keywords
- omega
- long chain
- cancer agents
- chain fat
- fat alcohol
- Prior art date
Links
- 239000002246 antineoplastic agent Substances 0.000 title abstract 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical group CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 229940034982 antineoplastic agent Drugs 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 125000005837 1,2-cyclopentylene group Chemical group [H]C1([H])C([H])([H])C([H])([*:1])C([H])([*:2])C1([H])[H] 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000651 prodrug Chemical class 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/553—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with halogen atoms or nitro radicals directly attached to ring carbon atoms, e.g. fluorouracil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/0006—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table compounds of the platinum group
- C07F15/0086—Platinum compounds
- C07F15/0093—Platinum compounds without a metal-carbon linkage
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01131049 | 2001-12-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE413390T1 true ATE413390T1 (de) | 2008-11-15 |
Family
ID=8179720
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT02805778T ATE413390T1 (de) | 2001-12-31 | 2002-12-30 | Langkettige fettalkoholsubstituenten in mitteln gegen krebs |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20040266747A1 (de) |
| EP (1) | EP1465876B1 (de) |
| JP (1) | JP2005513156A (de) |
| AT (1) | ATE413390T1 (de) |
| AU (1) | AU2002367194B2 (de) |
| CA (1) | CA2464937A1 (de) |
| DE (1) | DE60229779D1 (de) |
| ES (1) | ES2316651T3 (de) |
| WO (1) | WO2003055864A1 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1744785A1 (de) * | 2004-04-30 | 2007-01-24 | Kopran Research Laboratories Limited | Hydroxyalkylderivate von biologischen wirkstoffen |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH633280A5 (de) * | 1978-03-09 | 1982-11-30 | Elkawi Ag | 5-fluoruracil-derivate und diese verbindungen enthaltende arzneimittel. |
| JPS5668674A (en) * | 1979-11-08 | 1981-06-09 | Shionogi & Co Ltd | 5-fluorouracil derivative |
| EP0167310B1 (de) * | 1984-06-27 | 1991-05-29 | Johnson Matthey Public Limited Company | Platinkoordinationsverbindungen |
| DE3432320A1 (de) * | 1984-09-03 | 1986-03-13 | Behringwerke Ag, 3550 Marburg | Cis-platin-komplexe mit einem pentaerythritderivat als liganden, verfahren zu ihrer herstellung und diese verbindungen enthaltendes pharmazeutisches mittel |
| GB9322795D0 (en) * | 1993-11-05 | 1993-12-22 | Wellcome Found | Novel compounds |
| WO2001036431A1 (en) * | 1999-11-15 | 2001-05-25 | Parker Hughes Institute | Diamino platinum (ii) antitumor complexes |
-
2002
- 2002-12-30 US US10/494,441 patent/US20040266747A1/en not_active Abandoned
- 2002-12-30 WO PCT/EP2002/014809 patent/WO2003055864A1/en active Application Filing
- 2002-12-30 CA CA002464937A patent/CA2464937A1/en not_active Abandoned
- 2002-12-30 DE DE60229779T patent/DE60229779D1/de not_active Expired - Lifetime
- 2002-12-30 JP JP2003556395A patent/JP2005513156A/ja active Pending
- 2002-12-30 AU AU2002367194A patent/AU2002367194B2/en not_active Ceased
- 2002-12-30 ES ES02805778T patent/ES2316651T3/es not_active Expired - Lifetime
- 2002-12-30 EP EP02805778A patent/EP1465876B1/de not_active Expired - Lifetime
- 2002-12-30 AT AT02805778T patent/ATE413390T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1465876B1 (de) | 2008-11-05 |
| EP1465876A1 (de) | 2004-10-13 |
| JP2005513156A (ja) | 2005-05-12 |
| WO2003055864A1 (en) | 2003-07-10 |
| AU2002367194A1 (en) | 2003-07-15 |
| DE60229779D1 (de) | 2008-12-18 |
| CA2464937A1 (en) | 2003-07-10 |
| ES2316651T3 (es) | 2009-04-16 |
| US20040266747A1 (en) | 2004-12-30 |
| AU2002367194B2 (en) | 2008-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1120189T1 (el) | Λιπιδια, συμπλοκα λιπιδιων και χρηση εξ' αυτων | |
| BR0211332B1 (pt) | composiÇço poliolefÍnica, processo para a preparaÇço de dita composiÇço, bem como artigo compreendendo a mesma. | |
| MX2013002558A (es) | Derivado de imidazol de heteroanillo fusionado que tiene efecto de activacion de proteina cinasa activada por monofosfato de adenosina (amk). | |
| AR057023A1 (es) | Compuestos heterociclicos con propiedades inhibidoras de hiv-integrasa | |
| SV2002000478A (es) | Derivados de tiofeno utiles como anticancerosos ref. pc10795aagl/bb | |
| CO5690593A2 (es) | Nuevos derivados de pirimidin 2-amina | |
| AR031597A1 (es) | Compuestos piperidinos,un proceso para su preparacion, composiciones farmaceuticas,y el uso de dichos compuestos para la fabricacion de un medicamento para uso como inhibidores ccr-3 | |
| ECSP066548A (es) | 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogena cronica | |
| KR960705810A (ko) | 퀴나졸린 유도체(quinazoline derivatives) | |
| CY1113812T1 (el) | Ετεροκυκλικη ενωση και φαρμακευτικη συνθεση αυτης | |
| AR069436A1 (es) | Compuestos de piridina | |
| CY1111748T1 (el) | Παραγωγα 7-αλκυνυλο-1.8-ναφθυριδονων, η παρασκευη τους και η εφαρμογη τους στη θεραπευτικη | |
| DK1045021T3 (da) | Sammensætning omfattende en blanding af alkoxylerede mono- di- og triglycerider og glycerol | |
| BRPI0607407A2 (pt) | derivados de mentano carboxamida tendo propriedades de refrescáncia | |
| DE60102161D1 (de) | Cumarin-derivate mit comt hemmender wirkung | |
| DE69126009T2 (de) | Zyklische (Hetero)Acetale nitrosubstituierter Benzaldehyde mit Wirkung gegen Krebs | |
| CY1111569T1 (el) | Μονολυσινικα αλατα αζολικων ενωσεων | |
| ATE413390T1 (de) | Langkettige fettalkoholsubstituenten in mitteln gegen krebs | |
| ATE517087T1 (de) | Cbp-verbindung | |
| UY27930A1 (es) | Derivados de tiazol | |
| UY29801A1 (es) | Derivados de quinazolina, sales farmacéuticamente aceptables de las mismas, composiciones farmacéuticas conteniéndolas, procedimientos de preparación y aplicaciones. | |
| FI942294A0 (fi) | Bentsopyraanijohdannaiset ja niiden käyttö | |
| DK0458387T3 (da) | Isochromanderivater | |
| MX2009006164A (es) | Fosfonatos reactivos. | |
| CO5080802A1 (es) | Nuevos compuestos heterociclicos inhibidores de la fosfodiesteresa iv y su formulacion y uso como productos farmaceuticos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |